Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization
NCT ID: NCT03290404
Last Updated: 2018-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
292 participants
OBSERVATIONAL
2017-11-13
2018-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The maximal recommended dose of Lidocaine adrenaline in the upper limb is 500 mg. The use of ultrasound helps guiding the locoregional anesthesia, and allows to decrease the AL concentration, thus decreasing the risks.
No previous study estimated a concentration of lidocaine lower than 1,5 % to realize upper limb surgery by axillary block.
The literature overestimating probably the rate of failure of the locoregional anesthesia under ultrasound-guidance, we suggest to estimate the rate of failure of the axillary block ultrasound-guided with the lidocaine 1 % adrenaline for realizing upper limb surgery in standard practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Two Different Volumes of Anesthesia Drug in Forearm Surgery
NCT01216488
Axillary Block in Association With Analgesic Truncal Blocks at the Elbow for Wrist Surgery.
NCT04046744
Ultrasound Guided Intercostobrachial Nerve Block
NCT02805582
US Guided Axillary Block With Only One Injection
NCT02334176
Ultrasound-guided Versus Blind Technique in Medial Brachial Cutaneous Nerve and Intercostobrachial Nerve Blocks
NCT02940847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult
* non-opposition
Exclusion Criteria
* medical advice to local anaesthetic
* Allergy
* Pregnant
* ASA 3 or more
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Instruction des Armées
Brest, , France
CHRU de Brest
Brest, , France
Centre Hospitalier Intercommunal de Cornouaille
Quimper, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC17.0072 fLACON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.